Thomas Marjot

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Roux En Y Gastric Bypass

Respiratory Syndrome Coronavirus

Prognostic Factors

Top Venues

Hepatology communications

JGH open : an open access journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Marjot, Jeremy W Tomlinson, Leanne Hodson, David W Ray
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD. Gut (2023)
Jean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg
COVID-19 and liver disease. Gut 71 (11) (2022)
Luke Baldelli, Thomas Marjot, Eleanor Barnes, Alfred Sidney Barritt, Gwilym J Webb, Andrew M Moon
SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. Gut and liver (2022)
Thomas Marjot, Gwilym J Webb, Alfred S Barritt, Andrew M Moon, Zania Stamataki, Vincent Wai-Sun Wong, Eleanor Barnes
COVID-19 and liver disease: mechanistic and clinical perspectives. Nature reviews. Gastroenterology & hepatology 18 (5) (2021)
Tingyan Wang, David Anthony Smith, Cori Campbell, Steve Harris, Hizni Salih, Kinga A Várnai, Kerrie Woods, Theresa Noble, Oliver Freeman, Zuzana Moysova, Thomas Marjot, Gwilym J Webb, Jim Davies, Eleanor Barnes, Philippa Clare Matthews
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019. Hepatology communications 5 (9) (2021)
Andrew M Moon, Gwilym J Webb, Ignacio García-Juárez, Anand V Kulkarni, Gupse Adali, David K Wong, Beth Lusina, Georgios N Dalekos, Steven Masson, Brandon M Shore, Eleanor Barnes, Alfred Sidney Barritt, Thomas Marjot
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. Hepatology communications (2021)
Thomas Marjot, Charlotte J Green, Catriona A Charlton, Thomas Cornfield, Jonathan Hazlehurst, Ahmad Moolla, Sarah White, Jane Francis, Stefan Neubauer, Jeremy Fl Cobbold, Leanne Hodson, Jeremy W Tomlinson
Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. JGH open : an open access journal of gastroenterology and hepatology 4 (3) (2019)
Ahmad Moolla, Kenzo Motohashi, Thomas Marjot, Amelia Shard, Mark Ainsworth, Alastair Gray, Rury Holman, Michael Pavlides, John D Ryan, Jeremy W Tomlinson, Jeremy F Cobbold
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health. Frontline gastroenterology 10 (4) (2019)